Oral Abrocitinib for Treatment of Refractory Alopecia Areata: A Retrospective Study

October 2024 in “ Journal of the American Academy of Dermatology ”

Yujing Zhang, Xiaodong Fang, Xiangqian Li, Yan Zhao, Jianzhong Zhang, Wei Zhao, Cheng Zhou

We don't know much about this study yet.

We're maintaining the world's largest resposity of hair loss research. You can help out the community by sending a PDF of this study here . Not sure how to get a study's PDF? You can email the authors of the study.

View this study on jaad.org →

Discuss this study in the Community →

Research cited in this study

2 / 2 results

research European Expert Consensus Statement on the Systemic Treatment of Alopecia Areata

4 citations , January 2024 in “JEADV. Journal of the European Academy of Dermatology and Venereology/Journal of the European Academy of Dermatology and Venereology”

Baricitinib and ritlecitinib are recommended for severe alopecia areata, with other treatments available off-label.

research Successful Treatment of Alopecia Universalis With Abrocitinib: A Case Report

19 citations , August 2023 in “Journal of Dermatological Treatment”

Abrocitinib may effectively treat stubborn alopecia universalis.

Related Research

1 / 1 results

research Twenty Nail Dystrophy with Alopecia Areata in an Atopic Child

April 2019 in “International journal of research in dermatology”

A child with rough nails also had hair loss and allergies.